David A. Leather

GlaxoSmithKline R&D
Brentford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Misconceptions of Traits to Predict Response to Inhaled Corticosteroid and Bronchodilator Therapies in Asthma: A Narrative Review.

Misconceptions of Traits to Predict Response to Inhaled Corticosteroid and Bronchodilator Therapies in Asthma: A Narrative Review.

Journal: Pulmonary therapy

Published: June 12, 2025

Understanding the Contribution of Community Organisations to Healthy Ageing and Integrated Place-Based Care: Evidence from Integrated Care Data.

Understanding the Contribution of Community Organisations to Healthy Ageing and Integrated Place-Based Care: Evidence from Integrated Care Data.

Journal: Healthcare (Basel, Switzerland)

Published: September 20, 2023

Mortality after admission with pneumonia is higher than after admission with an exacerbation of COPD.

Mortality after admission with pneumonia is higher than after admission with an exacerbation of COPD.

Journal: The European respiratory journal

Published: November 09, 2021

Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis.

Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis.

Journal: Thorax

Published: August 17, 2021

Moving towards a Treatable Traits model of care for the management of obstructive airways diseases.

Moving towards a Treatable Traits model of care for the management of obstructive airways diseases.

Journal: Respiratory medicine

Published: April 28, 2021

Key Learnings from Running an Extension Study to a Real-World Effectiveness Trial: The Extended Salford Lung Study.

Key Learnings from Running an Extension Study to a Real-World Effectiveness Trial: The Extended Salford Lung Study.

Journal: Advances in therapy

Published: April 20, 2021

Patient and healthcare professional experiences of the Salford Lung Studies: qualitative insights for future effectiveness trials.

Patient and healthcare professional experiences of the Salford Lung Studies: qualitative insights for future effectiveness trials.

Journal: Trials

Published: March 02, 2020

Improving primary care management of asthma: do we know what really works?

Improving primary care management of asthma: do we know what really works?

Journal: NPJ primary care respiratory medicine

Published: December 16, 2019

Community pharmacy: a crucial enabler in creating the effectiveness study environment in the Salford Lung Studies.

Community pharmacy: a crucial enabler in creating the effectiveness study environment in the Salford Lung Studies.

Journal: The International journal of pharmacy practice

Published: November 18, 2019

Impact of socioeconomic status on participation and outcomes in the Salford Lung Studies.

Impact of socioeconomic status on participation and outcomes in the Salford Lung Studies.

Journal: ERJ open research

Published: August 06, 2019

Real-World Data and Randomised Controlled Trials: The Salford Lung Study.

Real-World Data and Randomised Controlled Trials: The Salford Lung Study.

Journal: Advances in therapy

Published: July 24, 2019

Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study design.

Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study design.

Journal: ERJ open research

Published: March 04, 2019

Showing 1-12 of 35

Last Updated: 09/26/2026